Intrauterine Misoprostol in Cesarean Delivery: Effect on Postpartum Hemorrhage
Evaluation of the Efficacy of Intrauterine Misoprostol Administration on Postpartum Hemorrhage in Cesarean Operations
This prospective, randomized, controlled, two-arm study evaluates whether adding intrauterine (uterine cornual) misoprostol 400 mcg to standard oxytocin reduces postpartum blood loss in term women undergoing elective cesarean delivery. Participants are randomized 1:1 to standard oxytocin alone or standard oxytocin plus misoprostol. The primary outcome is the change in hemoglobin and hematocrit from preoperative values to 6, 24 and 48 hours after surgery.
研究概览
详细说明
A total of 142 women (71 per group) will be enrolled. The study group receives standard oxytocin plus a single 400 mcg dose of misoprostol placed in the uterine cornual region after placental delivery; the control group receives standard oxytocin only. Hemoglobin and hematocrit are measured before surgery and at 6, 24 and 48 hours afterwards, and participants are seen on postoperative day 10 for late complications and adverse events. The surgical team is not masked; participants are not informed of their allocation. An interim safety analysis is planned after 50 participants.
研究类型
注册 (估计的)
阶段
- 第四阶段
联系人和位置
学习联系方式
- 姓名:Halil Gümüş, MD
- 电话号码:+90 537 673 47 49
- 邮箱:dr.halil.gumusrc@gmail.com
学习地点
-
-
-
Istanbul、土耳其(türkiye)
- Bagcilar Training and Research Hospital, Department of Obstetrics and Gynecology
-
接触:
- Halil Gümüş, MD
- 电话号码:+90 537 673 47 49
- 邮箱:dr.halil.gumusrc@gmail.com
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Age 18-45 years
- Term pregnancy (37 weeks or more)
- Elective cesarean section planned
- ASA I-II
- Written informed consent signed
Exclusion Criteria:
- History of coagulopathy or active bleeding disorder
- Anticoagulant use
- Hemoglobin < 10 g/dL
- Active thromboembolic disease
- Severe hepatic failure
- BMI > 35 kg/m2
- Type 1 diabetes with diabetic nephropathy
- Chronic hypertension
- Gestational hypertension, preeclampsia, eclampsia or HELLP syndrome
- Placenta previa, placental abruption or placental pathology with high bleeding risk
- Multiple pregnancy
- Uterine anomalies
- Intrauterine fetal death
- Epilepsy (diagnosis or history)
- Active malignancy
- Known hypersensitivity to prostaglandins
- Refusal or withdrawal of consent
- Emergency-indicated cesarean sections (including those planned as elective but performed for fetal distress, uterine rupture or other emergency indications)
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Misoprostol plus standard oxytocin
Standard oxytocin plus a single 400 mcg dose of misoprostol placed in the uterine cornual region after delivery of the placenta during elective cesarean delivery. |
Misoprostol 400 mcg (2 x 200 mcg tablets), single dose placed in the uterine cornual region after delivery of the placenta, in addition to standard oxytocin. Standard oxytocin administered after delivery of the baby according to routine clinical practice (standard of care in both arms). |
|
有源比较器:Standard oxytocin
Standard oxytocin only, according to routine clinical practice, during elective cesarean delivery. |
Standard oxytocin administered after delivery of the baby according to routine clinical practice (standard of care in both arms). |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in hemoglobin from preoperative value to postoperative 6, 24 and 48 hours
大体时间:Preoperative, and 6, 24 and 48 hours after surgery
|
Hemoglobin (g/dL) measured before surgery and at 6, 24 and 48 hours after surgery; change from the preoperative value is compared between groups. |
Preoperative, and 6, 24 and 48 hours after surgery
|
|
Change in hematocrit from preoperative value to postoperative 6, 24 and 48 hours
大体时间:Preoperative, and 6, 24 and 48 hours after surgery
|
Hematocrit (%) measured before surgery and at 6, 24 and 48 hours after surgery; change from the preoperative value is compared between groups. |
Preoperative, and 6, 24 and 48 hours after surgery
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Need for blood transfusion
大体时间:From surgery until hospital discharge, up to 48 hours
|
Proportion of participants requiring blood transfusion after surgery. |
From surgery until hospital discharge, up to 48 hours
|
|
Need for additional uterotonic or hemostatic intervention
大体时间:During surgery and until hospital discharge, up to 48 hours
|
Proportion of participants requiring additional uterotonic agents or other hemostatic interventions. |
During surgery and until hospital discharge, up to 48 hours
|
|
Late postoperative complications and readmission
大体时间:Up to postoperative day 10
|
Late complications and hospital readmission assessed at the postoperative day 10 visit. |
Up to postoperative day 10
|
|
Misoprostol-related adverse events
大体时间:Up to postoperative day 10
|
Adverse events potentially related to misoprostol (e.g., fever, shivering, nausea, vomiting, diarrhea) recorded in both groups. |
Up to postoperative day 10
|
合作者和调查者
调查人员
- 首席研究员:Cem Yener, MD, Associate Professor、Bagcilar Training and Research Hospital
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- E-66291034-50.04-7274
- 248 (其他标识符:Istanbul Medipol University Clinical Research Ethics Committee)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.